On October 13, 2022, Xenetic Biosciences, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.178 USD | +2.17% | +11.13% | +21.11% |
Mar. 21 | Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | CLS Therapeutics Discloses its Views on Xenetic Biosciences | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.11% | 6.3M | |
-3.08% | 103B | |
+1.27% | 95.28B | |
+1.46% | 22.15B | |
-16.11% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.18% | 16.05B | |
+4.75% | 13.68B | |
+32.72% | 12.17B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences, Inc. announced that it has received $0.488835 million in funding from CLS Therapeutics, LLC